These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 11808931

  • 1. Iron as a comorbid factor in chronic viral hepatitis.
    Bonkovsky HL.
    Am J Gastroenterol; 2002 Jan; 97(1):1-4. PubMed ID: 11808931
    [No Abstract] [Full Text] [Related]

  • 2. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M.
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [Abstract] [Full Text] [Related]

  • 3. Phlebotomy: a promising treatment for chronic hepatitis C.
    Tanaka N, Kiyosawa K.
    J Gastroenterol; 2004 Jun; 39(6):601-3. PubMed ID: 15235885
    [No Abstract] [Full Text] [Related]

  • 4. Insulin resistance and iron perturbation in patients with chronic hepatitis C.
    Mascitelli L, Pezzetta F, Goldstein MR.
    Intern Med J; 2010 Feb; 40(2):168-9. PubMed ID: 20446965
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W, Pianko S, Warner S, Bowden S, Simpson I, Bowden D, Locarnini S.
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [Abstract] [Full Text] [Related]

  • 6. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
    Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F, Ferraro D, Cuccia L, Ruffo GB, Bronte F, Di Stefano R, Almasio PL, Craxì A.
    Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
    [Abstract] [Full Text] [Related]

  • 7. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
    Silva IS, Perez RM, Oliveira PV, Cantagalo MI, Dantas E, Sisti C, Figueiredo-Mendes C, Lanzoni VP, Silva A, Ferraz ML.
    J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
    [Abstract] [Full Text] [Related]

  • 8. MRI and iron-overload cardiomyopathy in thalassaemia.
    Pennell D.
    Circulation; 2006 Mar 21; 113(11):f43-4. PubMed ID: 16552847
    [No Abstract] [Full Text] [Related]

  • 9. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
    Ault P, Jones K.
    Clin J Oncol Nurs; 2009 Oct 21; 13(5):511-7. PubMed ID: 19793708
    [Abstract] [Full Text] [Related]

  • 10. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
    Yano M, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Shiono Y, Arao M, Ukai K, Ito H, Watanabe K, Yoshioka K.
    Am J Gastroenterol; 2002 Jan 21; 97(1):133-7. PubMed ID: 11808937
    [Abstract] [Full Text] [Related]

  • 11. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A, Hernández C, Simó R.
    Diabetes Metab Res Rev; 2009 Jul 21; 25(5):403-10. PubMed ID: 19444865
    [Abstract] [Full Text] [Related]

  • 12. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S, Casanova JM, Marco MP, Craver L, Martín M, Fernández E.
    Nefrologia; 2002 Jul 21; 22(6):570-3. PubMed ID: 12516291
    [Abstract] [Full Text] [Related]

  • 13. [Significance of iron reduction for the therapy of chronic hepatitis C].
    Nozić D, Balint B, Stanković N, Dimitrijević J, Nesković G.
    Vojnosanit Pregl; 2005 Feb 21; 62(2):161-4. PubMed ID: 15787170
    [Abstract] [Full Text] [Related]

  • 14. Iron depletion and response to interferon in chronic hepatitis C.
    Carlo C, Daniela P, Giancarlo C.
    Hepatogastroenterology; 2003 Feb 21; 50(53):1467-71. PubMed ID: 14571765
    [Abstract] [Full Text] [Related]

  • 15. The role of iron in patients after bone marrow transplantation.
    de Witte T.
    Blood Rev; 2008 Dec 21; 22 Suppl 2():S22-8. PubMed ID: 19059053
    [Abstract] [Full Text] [Related]

  • 16. [Iron overload. Diagnosing and treating prior to complications].
    Deugnier Y, Bourel M.
    Rev Prat; 2006 Dec 15; 56(19):2109-10. PubMed ID: 17416046
    [No Abstract] [Full Text] [Related]

  • 17. Management of iron overload. Introduction.
    Cappellini MD.
    Blood Rev; 2008 Dec 15; 22 Suppl 2():S13. PubMed ID: 19059051
    [No Abstract] [Full Text] [Related]

  • 18. The deleterious effects of iron overload in patients with myelodysplastic syndromes.
    Dreyfus F.
    Blood Rev; 2008 Dec 15; 22 Suppl 2():S29-34. PubMed ID: 19059054
    [Abstract] [Full Text] [Related]

  • 19. Iron, HCV, and liver cancer: hard metal setting the pace?
    Mueller S, Afdhal NH, Schuppan D.
    Gastroenterology; 2006 Jun 15; 130(7):2229-34. PubMed ID: 16762645
    [No Abstract] [Full Text] [Related]

  • 20. Iron toxicity as a potential factor in AMD.
    Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL.
    Retina; 2007 Oct 15; 27(8):997-1003. PubMed ID: 18040235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.